Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease

Summary

We aimed to evaluate the hypothalamus-pituitary-adrenal axis in autosomal dominant polycystic kidney disease (ADPKD) patients. Twenty two ADPKD patients and 27 healthy subjects were enrolled.

Conditions

• Autosomal Dominant Polycystic Kidney Disease

Interventions

DRUG

Tetracosactin

1 microgram tetracosactin, intravenous injection, once for the test

Sponsors & Collaborators

• Istanbul University

  lead OTHER

Principal Investigators

• Tevfik Ecder, Professor · Istanbul University, Istanbul Medical Faculty, Department of Internal Medicine, Division of Nephrology

• Fatih Tufan, Fellow · Istanbul University Istanbul Medical Faculty Department of Internal Medicine

• Neşe Çolak, Professor · Istanbul University Istanbul Medical Faculty Department of Internal Medicine Division of Endocrinology

• Bora Uslu, Fellow · Istanbul University Istanbul Medical Faculty Department of Internal Medicine

• Kültigin Türkmen, Fellow · Istanbul University Istanbul Medical Faculty Department of Internal Medicine

• Mükremin Uysal, Fellow · Istanbul University Istanbul Medical Faculty Department of Internal Medicine

• Nilüfer Alpay, Fellow · Istanbul University Istanbul Medical Faculty Department of Internal Medicine

• Rian Dişçi, Professor · Istanbul University Istanbul Medical Faculty Department of Public Health

• Bledi Çerkezi, Fellow · Istanbul University Istanbul Medical Faculty Department of Radiology

Study Design

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

20 Years

Max Age

56 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2006-09-30

Primary Completion

2007-09-30

Completion

2007-09-30

Countries

• Turkey (Türkiye)

Study Locations